Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 1/2016

01-01-2016 | Images in Metabolic Medicine

Nervous system involvement in Farber disease

Authors: Alberto M. Cappellari, Marta Torcoletti, Fabio Triulzi, Fabrizia Corona

Published in: Journal of Inherited Metabolic Disease | Issue 1/2016

Login to get access

Abstract

A 30 months-old boy with Farber disease developed nystagmus 12 months after hematopoietic stem cell transplantation (HSCT). At 40 months, gait ataxia was evident, and brain MRI showed increased size of pericerebellar sulci and 4th ventricle. EMG showed denervation in the tongue and upper limb muscles, consistent with motor neuron disease. HSCT improves the peripheral manifestations of Farber disease, but may not prevent the progressive neurological deterioration.
Literature
go back to reference Torcoletti M, Petaccia A, Pinto RM et al (2014) Farber disease in infancy resembling juvenile idiopathic arthritis: identification of two new mutations and a good early response to allogeneic haematopoietic stem cell transplantation. Rheumatology (Oxford) 53:1533–1534CrossRef Torcoletti M, Petaccia A, Pinto RM et al (2014) Farber disease in infancy resembling juvenile idiopathic arthritis: identification of two new mutations and a good early response to allogeneic haematopoietic stem cell transplantation. Rheumatology (Oxford) 53:1533–1534CrossRef
go back to reference Yeager AM, Uhas KA, Coles CD et al (2000) Bone marrow transplantation for infantile ceramidase deficiency (Farber disease). Bone Marrow Transplant 26:357–363PubMedCrossRef Yeager AM, Uhas KA, Coles CD et al (2000) Bone marrow transplantation for infantile ceramidase deficiency (Farber disease). Bone Marrow Transplant 26:357–363PubMedCrossRef
go back to reference Zhou J, Tawk M, Tiziano FD et al (2012) Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1. Am J Hum Genet 91:5–14PubMedPubMedCentralCrossRef Zhou J, Tawk M, Tiziano FD et al (2012) Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1. Am J Hum Genet 91:5–14PubMedPubMedCentralCrossRef
Metadata
Title
Nervous system involvement in Farber disease
Authors
Alberto M. Cappellari
Marta Torcoletti
Fabio Triulzi
Fabrizia Corona
Publication date
01-01-2016
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 1/2016
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-015-9890-0

Other articles of this Issue 1/2016

Journal of Inherited Metabolic Disease 1/2016 Go to the issue